SAN DIEGO, CA—Patients with acute gouty arthritis who received canakinumab administered via a prefilled syringe experienced significantly greater pain relief and reduced risk of new attacks compared ...
DUBLIN--(BUSINESS WIRE)--The "Prefilled Syringe Market Report: Trends, Forecast, and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering. The future of the prefilled ...
The US Food and Drug Administration (FDA) has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a prefilled syringe presentation to prevent shingles (herpes zoster). This ...
The prefilled syringe is provided as a 300mg/2mL (150mg/mL) ready-to-use solution for subcutaneous injection and does not require additional reconstitution or dilution. Takhzyro ® (lanadelumab-flyo) ...
Since Roche gained approval for its eye disease medication Vabysmo in 2022, it has stormed a market dominated by Regeneron and Bayer’s Eylea. Friday, Roche took another step in its advancement of the ...
DUBLIN--(BUSINESS WIRE)--The "Prefilled Syringe Fill / Finish Services Market, 2020-2030" report has been added to ResearchAndMarkets.com's offering. This report features an extensive study of the ...
The existing vaccine consists of two vials -- a lyophilized (powder) antigen and a liquid adjuvant -- that health care professionals combine prior to administration. The new prefilled syringe ...
List of PPS Fill Finish Service Providers · GlobeNewswire Inc. Location of Manufacturing Location of Manufacturing · GlobeNewswire Inc. Number of Barrel Chambers Number of Barrel Chambers · ...
Among drug delivery devices, prefilled syringes represent one of the fastest growing primary packaging formats, which are also designed for dose administration. In fact, over the past ten years, there ...
VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...
Seeking to ramp up the nation’s capacity to administer a possible COVID-19 vaccine, the Trump administration has signed a $138 million deal with the makers of an innovative syringe designed to be used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results